The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,676,954 in first-year total cost, median $681,852.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMST-H (15)]1
- Special Emphasis Panel[ZRG1 IMST-K (14)]1
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]1
Most frequent institutions
- COLLAGEN MEDICAL, LLC1
- CYTEX THERAPEUTICS INC.1
- PLENOPTIKA, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Commercialization of automated mobile device for accurate comprehensive refraction2R44EY025452-04 | CHU, GARY YIU-KINDAVE, SHIVANG RAJENDRA | PLENOPTIKA, INC., MA | $681,852 | ZRG1 |
| 2021 | Molecular Imaging Agent to Detect Thrombus2R44HL156606-05 | HUMBLET, VALERIE | COLLAGEN MEDICAL, LLC, MA | $496,849 | ZRG1 |
| 2020 | Cartilage Regeneration with Tunable Inflammation Resistance2R44AG059310-03 | ESTES, BRADLEY T | CYTEX THERAPEUTICS INC., NC | $1,498,253 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.